HDFC Bank, ICICI Bank are screaming buys at current prices: Nischal Maheshwari

Posted on:
Key Points

Nischal Maheshwari, CEO, Centrum Broking, says we are more positive on companies which are green oriented and we are strongly betting on that..

Of course, Paytm is a bit of a dangerous bet right now but apart from that, Zomato has been seeing a good amount of commentary coming from the brokerages, the management is fairly positive and for PB Fintech there is this added boost of the composite license as well..

Nischal Maheshwari: Yes, both these stocks, Zomato and PB Fintech, have been my favourites in the whole space and the logics have been basically that both are market leaders and it takes a lot of time and effort and money to get into these kind of pole positions for both these stocks..

We prefer the domestics more than the international names and Sun Pharma has been a top pick and that continues to be both domestic as well as international, continues to be doing pretty good..

The other space which we like within the pharma or a broader healthcare space is the hospital, I think that space is doing pretty well and has a very strong visibility...

You might be interested in

Largecap IT, Reliance provide opportunities for very long-term investors: Neeraj Dewan

20, Mar, 23

Reliance had been in the Rs 2,200-2,700 band for quite some time. It has come closer to the lower end of the band and there are definitely positive triggers which will come later – maybe listing of Jio or the retail arm getting demerged into a different company. All those triggers will come eventually. So valuation-wise, after the correction, it looks more attractive.

Maruti and UltraTech like Virat Kohli and Rohit Sharma, good to have in your portfolio: Hemang Jani

24, Oct, 23

“There is a mini bubble in the broader market and one needs to be selective about that. Do not be too quick to jump into an index which has gone up 35% and stocks that have gone up 3X-5X. Okay, the stock has corrected 5%, 10%, let it stabilise, do some homework and then start nibbling.”

3 pharma stocks to buy on dips; 3 banks that may outperform: Sanjiv Bhasin

10, Oct, 23

“ HDFC Bank is a very good long-term and a slightly medium-term play. I do not rule out Bank Nifty going back to test 46,000 in this month itself and I would be very bullish on select banks like AU Bank, IDFC and RBL Bank which are three banks where we are taking exposure and we think can outperform.”

A shift to defensives like FMCG & pharma apparent: Rohit Srivastava

08, Nov, 23

19,450 is going to be the first hurdle that Nifty is facing. We are pretty close to that and once we get past that, we should head towards 19,700. Even in the Bank Nifty, we are very close to the 40-day average, which is around 43,680. We can go towards 43,800 or slightly higher.